In fact, E6 antiapoptosis functioning through the PI3K/akT/EGFR pathway may explain the NSCLC tumorigenesis in patients with EGFR gene mutation and HPV infection [30]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.